A detailed history of Virtu Financial LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 14,152 shares of EQ stock, worth $8,632. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,152
Holding current value
$8,632
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$0.64 - $1.13 $9,057 - $15,991
14,152 New
14,152 $12,000
Q1 2023

May 01, 2023

SELL
$0.56 - $1.24 $5,374 - $11,901
-9,598 Reduced 33.89%
18,724 $14,000
Q4 2022

Feb 15, 2023

BUY
$0.83 - $2.26 $3,470 - $9,449
4,181 Added 17.32%
28,322 $31,000
Q3 2022

Nov 07, 2022

BUY
$1.93 - $3.14 $46,592 - $75,802
24,141 New
24,141 $54,000
Q1 2021

May 19, 2021

SELL
$5.03 - $10.5 $91,782 - $191,593
-18,247 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$3.48 - $6.58 $63,499 - $120,065
18,247 New
18,247 $98,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $21M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.